TNX-102 SL has the potential to be the first member of a new class of analgesic drugs for fibromyalgia and the first new drug for treating fibromyalgia in more than 15 years, if approved by FDA NDA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results